Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1274 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
BELUMOSUDIL
Rezurock
Drug-drug Interaction Autoimmune Diseases Fibrotic Disease
KD025-107NANCT03530995Tabulated Results
BELUMOSUDIL
Rezurock
Autoimmune Diseases Fibrosis
KD025-108NANCT03907540Tabulated Results
BELUMOSUDIL
Rezurock
Hepatic Impairment
KD025-109/POP17629NANCT04166942Summary
BELUMOSUDIL
Rezurock
Bioavailability
KD025-111NANCT04735822Summary
BELUMOSUDIL
Not Marketed
Psoriasis Vulgaris
KD025-205/ACT17656NANCT02106195Tabulated Results
BELUMOSUDIL
Not Marketed
Psoriasis Vulgaris
KD025-206/DFI17657NANCT02317627Tabulated Results
BELUMOSUDIL
Not Marketed
Idiopathic Pulmonary Fibrosis
KD025-207 / EFC17630NANCT02688647Tabulated Results
BELUMOSUDIL
Rezurock
Chronic Graft Versus Host Disease (cGVHD)
KD025-208 / ACT17631NANCT02841995Publication reference
BELUMOSUDIL
Not Marketed
Chronic Plaque Psoriasis
KD025-211/EFC17658NANCT02852967Tabulated Results
BELUMOSUDIL
Rezurock
Chronic Graft Versus Host Disease (cGVHD)
KD025-213 / DRI17633NANCT03640481Publication reference

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted